CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-25 | Simon Barry J. Director | Grant or award · Restricted Stock Units | +114,399 | 114,399 | ||
| 2023-08-25 | LAUER REGAN J Chief Accounting Officer | Grant or award · Restricted Stock Units | +65,744 | 65,744 | ||
| 2023-08-25 | Sachs David C. Chief Financial Officer | Grant or award · Restricted Stock Units | +141,489 | 141,489 | ||
| 2023-06-15 | LAUER REGAN J Chief Accounting Officer | Option exercise | +21,030 | 21,030 | ||
| 2023-06-15 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −21,030 | 42,061 | ||
| 2023-06-13 | Selecky Christobel Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-13 | MAXWELL LINDA Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-13 | Cohen Cheryl Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-13 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-13 | Brennan John Owen Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-13 | BLASZYK MICHAEL D Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-05 | BLASZYK MICHAEL D Director | Purchase | +23,430 | $2.72 | $64K | 23,430 |
| 2023-06-05 | BLASZYK MICHAEL D Director | Purchase | +48,000 | $2.77 | $133K | 71,430 |
| 2023-06-05 | BLASZYK MICHAEL D Director | Purchase | +485 | $2.75 | $1K | 71,915 |
| 2023-06-02 | Brennan John Owen Director | Purchase | +5,000 | $2.74 | $14K | 5,000 |
| 2023-06-02 | Brennan John Owen Director | Purchase | +10,000 | $2.80 | $28K | 15,000 |
| 2023-06-02 | Brennan John Owen Director | Purchase | +10,000 | $2.90 | $29K | 25,000 |
| 2023-06-01 | Clark Wesley Director | Purchase | +7,000 | $2.91 | $20K | 8,000 |
| 2023-05-12 | SOON-SHIONG PATRICK See remarks | Purchase · Convertible Promissory Note | +0 | $30,445,859.00 | $0 | |
| 2023-02-05 | Adcock Richard CEO & President | Option exercise | +83,333 | 227,774 |
Page 10 of 12 · 226 trades